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ABSTRACT 
The present research was designed to determine if a single LSD 
experience produces a detectable change in the electrical potential of 
the brain, and if so, how long that change lasts, and to examine the 
changes in the electrical potential of the brain associated with 
Aemogenic and hypnogenic hallucinations. Four studies were conducted 
measuring the electrical potential between the front and back of the 
head in monkeys and humans. The frontal potential was shown to shift 
negatively with the use of LSD-type psychedelics but not with marijuana 
compounds. LSD caused the potential in humans to shift into the range 
commonly exhibited by hallucinating schizophrenics. LSD-25 in a monkey 
caused an extreme negative shift, while brom-LSD caused a small negative 
shift, and THC caused no shift. There were no consistent shifts asso-
ciated with hypnosis or hypnotic phenomena such as hypnogenic halluci-
nations or hypnoanalgesia. The results indicated: that LSD, unlike 
marijuana compounds, caused a long-lasting but limited neurochemical 
change in the user; that these neurochemical changes were not due to 
hallucinations per se but may or may not have accompanied them; and 
that chemogenic hallucinations and hypnotic hallucinations were not 
based on a common physiological mechanism. 
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INTRODUCTION 
The present series of studies was undertaken to examine some 
electrophysiological concomitants of hallucinations associated with the 
use of psychedelic drugs (such as LSD and marijuana) , and with hypnoti-
cally-induced hallucinations. Some of the main concerns were: to 
replicate some of the recent work of M. A. Cowen, who has published 
thirty-two papers on a particular electrophysiological technique, of 
which there are no replications by any other laboratory; to determine 
whether or not LSD produces negative TCDC shifts in humans; and to exam-
ine the differences between chemogenic and hypnogenic hallucinations. 
The primary research tool in the present investigation was the 
transcephalic direct current potential (TCDC) measured across the 
frontal and occipital areas. Although electroencephalography is the 
best known method of measuring the electrical activity of the brain, 
it is not the only method. Libet and Gerard (1941) discovered a new 
technique by measuring the electrical potential between the front and 
the back of the cortex. This potential is known as the TCDC. Record-
ings are usually taken over the frontal and occipital lobes (FO) with 
the frontal lobe as the reference point. However, in some studies, 
recordings have also been taken over the temporal lobes (TT) simul-
taneously with the FO recordings. 
Cowen (1967, 1970b) is the leading researcher of this TCDC 
potential and in testing over 500 "normal" (i.e., non-psychiatric) 
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subjects during a three-year period, found that virtually all had a 
TCDC(FO) potential between -18 mv and +20 mv, and that no subject 
exceeded a peak negativity of -30 mv. This -30 mv extreme was exceeded 
by four of a group of ten college students who had taken psychotomectic 
[sic] drugs (Friedman & Walker, 1970). Unfortunately, neither the nature 
of the drugs nor the peak TCDC(FO) was specified. Although Cowen (1970a) 
found that no "simple" schizophrenic surpassed a TCDC(FO) negativity of 
over -30 mv, this level was exceeded by at least 40% of 96 hallucinating 
schizophrenics. The diagnosis of "hallucinatory", however, was obtained 
from the patients' charts. The percentage was much higher in acute 
hallucinating schizophrenics and much lower in chronic hallucinating 
schizophrenics (Cowen, 1970a). Cowen and Cassals (1968) found signifi-
cant differences (p< 0.01) in the TCDC(FO) potentials between 53 schizo-
phrenics and 43 "normals". Cowen (1968) found a high positive correla-
tion between frontal negativity and auditory, visual, or tactile hallu-
cinations in schizophrenics. In the case of tactile hallucinations, the 
TCDC(FO) correlates of the hallucinators ranged from -30mv to -80 mv.' 
There were no significant differences between the TCDC(FO) of 43 
"normals" and 9 non-hallucinating psychiatric patients, but they differed 
significantly (p< 0.001) from 34 hallucinating schizophrenics. Although 
the subject who showed the most frontal negativity was almost always 
hallucinating, not all subjects were hallucinating at the time of test-
ing. These findings suggested a detectable bio-electrical change accom-
panying hallucinations. This raises the question of recency and fre-
quency. Could a single psychedelic experience produce the TCDC(FO) 
changes, and how long would these changes last? 
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Electrically, the TCDC potentials are the slowly changing 
aperiodic voltages recorded between specified diploic-emissary vein 
distributions on the intact surface of the head. They are highly corre-
lated with potentials of subjacent cortical sites (Ardini, 1961). With 
the frontal electrode as a reference, any increase of electrical activity 
in the frontal lobe produces a negative shift (frontal negativity) in the 
TCDC(FO). Similarly, with the left temporal electrode as reference, any 
increase in the electrical activity of the left temporal lobe produces a 
negative shift in the TCDC(TT). 
On the basis of many neurochemical studies, Cowen (1970b) has sug-
gested that any substance that increases the amount of glutamic acid or 
serotonin available to the brain should drive the TCDC(FO) negative. 
All conceivable surface voltage sources have been examined as generators 
of artifact. The electro-oculographic component, even with both eyes 
turned maximally upward, is less than 100 uv compared to TCDC(FO) poten-
tials of +40 mv to -25 mv extremes in normal humans. There is no appar-
ent direct-current component to either muscle activity per se or to EEG 
"brain waves". Scalp perspiration drives the TCDC(FO) positive and is 
controlled in all studies by use of an air-conditioned room (Cowen, 
1970b). Scalp resistance measurements are epithelium-dependent and are 
not correlated with TCDC potentials (Cowen, 1970b). At least two sus-
pected schizophrenic substances, bufotenin and 3, 4 dimethoxyphenethy-
laime (DMPEA) affect serotonin levels (Gottlieb, 1968) and also produce 
negative TCDC(FO) voltages. In the rat, bufotenin in 0.2 ug doses and 
DMPEA in 4.0 ug were effective in producing a negative TCDC(FO) (Cowen, 
1970b), although Cowen did not report the range nor the magnitude of the 
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shift. Analgesics produced a near zero TCDC(FO) recording presumably 
because of the depression of activity in the cortical sites. 
Functionally, frontal negativity correlates with "orienting pro-
cesses" whereby the brain reprograms itself to deal with novel and com-
plex situations (Cowen, 1968). Frontal positivity is associated with 
defensive reflexes and withdrawal from the environmental stimuli (Cowen, 
1967). Left temporal TCDC electro-negativity correlates with intensive 
recall and reprocessing of complex information. Cowen (1970b) has 
claimed differential characteristic TCDC abnormalities for various human 
psychotic states including senility, childhood autism, and schizophrenia 
although he did not specify the characteristics (except for the -30 mv 
peak in hallucinating schizophrenics). 
The Friedman and Walker study suggested that the use of "psycho-
tomectic" drugs causes negative TCDC(FO) shifts not unlike that seen in 
hallucinating schizophrenics. However, a major problem in assessing the 
validity of research using "street-drugs" (i.e., drugs illegally produced 
and marketed) is whether or not the street-drug was what it was repre-
sented to be; however, the action of many of the hallucinogens seem to 
be neuro-chemically similar. Much of the evidence accumulated over the 
past years on the separate effects of LSD, mescaline and psilocybin has 
in recent years been treated identically in distinguishing the subjec-
tive effects of the drugs. Isbell (1959) has postulated some common 
biochemical or physiological mechanism responsible for their effects 
and, like Abramson (1960) and Abramson & Rolo (1967), has administered 
both LSD and psilocybin in the same study of subjective effects of 
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hallucinogens. Malitz, Wilkens, & Esecover (1962) administered all 
three in the same study and reported similar hallucinogenic behaviour 
for all three. 
The most direct support for assuming the equivalence of these 
drugs comes from cross-tolerance studies. Tolerance to one of the 
hallucinogens is established by repeated administration (5-8 days) 
which blocks or inhibits the action of the other hallucinogens (Abramson, 
Skarlofsky, Baron & Fremont-Smith, 1958; Abramson, Rolo & Skarlofsky, 
1960; Isbell, Wolback & Miner, 1961). A new hallucinogen, 2, 5- dimethoxy-
4- methyl-amphetamine (DOM), has been found at dosages greater than 10 mg 
to produce effects which resemble those produced by LSD, mescaline and 
psilocybin (Hollister, et al., 1969; Snyder, Faillace, & Weingartner, 
1968; and Snyder, Faillace, & Hollister, 1967). 
Even if the equivalence of the hallucinogenic drugs is granted, 
there remains the possibility that the "street" drugs contained no 
pharmicologically active ingredients at all. Cheek, Newell, and Joffe 
(1970), in an analysis of street drugs, found: (a) that of 15 samples 
of alleged LSD, 14 were in fact LSD and one was Sernyl; (b) that of 13 
samples of alleged mescaline, seven were LSD, four were "STP" (DOM), one 
was aspirin, and one was chemically inactive; (c) of five alleged samples 
of psilocybin, four were LSD and one was chemically inactive. It is 
certain that the subject could distinguish, barring placebo effect, 
between the LSD-STP samples and the inert aspirin and gelatin powder. 
Sernyl, although producing many of the same effects of LSD, also causes 
tremor of the extremities. The Le Dain Commission (19 70) reported that 
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most street drugs in Canada are relatively pure, and contained LSD. 
The relation between hallucinations of schizophrenic, hypnotic, 
and chemogenic natures is uncertain. Bliss and Clarke (1962) suggested 
certain general relations, similarities, and differences among the 
varieties of abnormal visual experiences. The first main category is 
the abnormal visual experiences that occur in "normal" people, e.g., 
sensory isolation phenomena, hypnotic states, and the results of some 
functional neuroses and psychoses. These visions are usually described 
as realistic, rather than bizarre, and commonly as monochromactic or in 
pale colour. The second main category includes the visions of hypnogogic 
states, dreams, and sleep deprivation. All three conditions are asso-
ciated with semisomnolence and altered electroencephalographic activity. 
These are posed as the workings of the mind in a "twilight zone" between 
alertness and deep sleep, and presumably reflect the cortical dominance 
of the visual apparatus at that time. The visions caused by mescaline, 
LSD, and other hallucinogens, as well as those resulting from withdrawal 
states induced by drugs that depress the brain, are organized into a 
third category. In these instances, visual hallucinations are attribut-
able either directly to the disequilibrium or sudden withdrawal from the 
agents. These conditions seem to evoke bizarre, fantastic, and poly-
chromatic visions that differ radically from those in the first two 
categories. 
Solomon and Mendelson (1962) offered the following criteria in 
Table 1 for differentiating altered states of consciousness: insight, 
volition, and consciousness. 
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INSERT TABLE 1 ABOUT HERE 
Insight is the specific awareness of the reality or unreality of the 
sense perception in question. Volition distinguishes between mental 
activity which is voluntary and willed, as opposed to that which is 
spontaneous and uncontrolled. (Where volition is absent, there is a 
sense of "out-thereness".) Consciousness is simply an awareness of 
outer and inner reality. 
The nature of the relation between psychogenic and chemogenic 
hallucinations is uncertain. Although they differ as to volition and 
insight, many common features are shared: they are both polyopic, 
without size and shape constancy, with similar form-constants, and are 
resistant to the influence of the beholder. The Le Dain Commission 
(1970, p. 317) distinguished between true hallucinations and pseudo-
hallucinations : 
A true hallucination includes the belief that the 
abnormal perception is physically real, while a 
pseudo-hallucination is recognized as being "unreal" 
or a distortion of normal perception. Hallucinogenic 
drugs usually produce pseudo-hallucinations rather 
than true hallucinations, although in acute psychotic 
reactions "reality contact" may be lost. 
Perhaps the difference between true hallucinations and pseudo-halluci-
nations is the degree of attendant anxiety rather than differing bio-
chemical mechanisms. 
Some researchers have also claimed hallucinogenic effects for 
large doses of marijuana and hashish (Kluver, 1928; Ames, 1958; Keeler, 
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Reifler and Liptzin, 1968; and Keeler, 1968; Underleider, Fisher, 
Goldsmith, Fuller and Forgy, 1968). McGlothlin and West (1969) sum up 
these claims: 
In larger doses marijuana effects more closely resemble 
those of the hallucinogens than any other group of drugs. 
Most of the phenomena experienced with LSD, such as de-
personalization, marked visual and temporal distortion, 
and hallucinations have been observed with sufficiently 
large amounts of marijuana and especially with hashish. 
The effects are generally much milder and easier to 
control than those of LSD. 
Isbell, Gorodetzsk, Jasinski, Claussen, Spulak, and Korte (1967) have 
recently demonstrated a similar dose effect with tetrahydrocannabinol 
(THC), an active ingredient of marijuana, but found no cross tolerance 
to the THC in subjects tolerant to LSD. This would seem to indicate 
that the two drugs act by different mechanisms and yet cause the same 
psychological effects. 
Researchers have long been examining another type of psychogenic 
hallucination, that experienced by a subject while in a deep hypnotic 
trance. Halpern (1961) described an account of the induction of a 
complex, unstructured hallucination in a young girl that resembled a 
schizophrenic or chemogenic hallucination. The unstructured halluci-
nation experienced by the girl is decidedly rare but the induction of 
a positive hallucination is not. A positive hallucination is the per-
ceiving of a stimuli that is not there. Schneck (1953), Orne (1962), 
Spanos and Barber (1968), Bowers and Gilmore (1969), and Gray, Bowers, 
and Fenz (1970) have all reiterated that under deep trance, the subject 
may experience positive or negative hallucinations. The work of 
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Erickson and Erickson (1938), Rosenthal and Mele (1952), and Barber 
(1959) showed that subjects requested to hallucinate colours also 
hallucinated the appropriate negative after-image. 
Ludwig (1964), using highly structured positive hallucinations, 
has been able to produce narcotic drug effects and withdrawal symptoms 
in his subjects. That subjects can hallucinate is no longer questioned, 
but what relation hypnotically-induced hallucinations have with chemo-
genic and schizophrenic hallucinations is still conjecture. 
Ravitz (1951), who has done extensive case work with d.c. poten-
tial correlates of hypnosis, found changes representing either a decrease 
or an increase in potential in association with hypnotic phenomena. 
However, he did not find any consistency in the direction of change but 
this may be the result of the difference in electrode placement. He 
used temporal-chest placements. Friedman, Becker, and Bachman (1962), 
in a fascinating study on hypnoanalgesia using the now standard frontal-
occipital placements, found specific stable d.c. changes during hypnotic 
induction. More pertinent to the present paper, they found that hypno-
analgesia was accompanied by changes in the d.c. potential consistently 
in the positive direction, demonstrating similarity to general and local 
chemical anesthesia. It seems reasonable to expect that if the TCDC is 
similar for hypnotic and chemogenic analgesia, then the TCDC should also 
be similar for hypnotic and chemogenic hallucinations. 
One way of eliminating the varied legal and scientific problems 
(involving set, setting, and preconceived ideas about LSD) in researching 
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LSD is to use animals as subjects. Cowen (1970) has examined the 
effects of LSD on the TCDC in rats and rabbits showing a positive corre-
lation between peak negativity and reported strength of the hallucinogen 
involved. Thus far no work has been reported on the TCDC changes induced 
by LSD in primates, either human or non-human. 
Although, on the basis of the present study, it is easy to deter-
mine whether or not the TCDC(FO) changes during LSD intoxication in 
monkeys are equivalent to those changes exhibited by humans, it is 
impossible to determine whether or not the behavioural changes are also 
equivalent. Behavioural evidence that monkeys do experience halluci-
nations as a result of LSD is inadequate. Cole and Glees (196 7) have 
studied the effects of 100 ug/kg in monkeys and reported that the 
animals' odd behaviour, (clutching at the air) could only be explained 
on the basis of hallucinations. However, Evarts (1956) used a dose of 
1000 ug/kg of LSD in monkeys and found no such findings. Auerbach 
(1971) has trained monkeys to make a different operant response to an 
auditory signal when viewing slides of patterned stimuli as opposed to 
plain or blank slides. Subjects continued to make appropriate responses 
to pictures following the administration of 10 ug/kg of LSD; their 
failure to respond to blank slides as if they were patterned suggested 
that LSD is not hallucinogenic in non-human primates. 
The present research was designed to determine if a single LSD 
experience produces a negative TCDC(FO) shift in primates, how long that 
shift lasts, and to examine the TCDC(FO) correlates of chemogenic and 
hypnogenic hallucinations. 
STUDY I 
Purpose 
Study I was undertaken to determine whether or not a single 
hallucinogenic experience had a long-lasting effect on the electrical 
activity of the brain. Cowen reported a high positive correlation 
between excessive frontal negativity and schizophrenic hallucinations. 
Additionally, Friedman and Walker reported excessive frontal negativity 
in a group of college students who used psychotomectic drugs. This 
suggested a connection between hallucinogenic substances and negative 
TCDC(FO) recordings. 
Method 
Subjects: Ten LSD-naive subjects, three female and seven male, between 
the ages of 18 and 24 participated in this study. The subjects were all 
part of the university community who had volunteered for the experiment 
advertised by a circular designed to recruit students already intending 
to take LSD. The circular is presented in Appendix A. Those who had 
experienced LSD prior to volunteering were tested, but their results 
were excluded from the present study. 
Apparatus: All subjects were tested while seated in a soundproof, air-
conditioned, visually monotonous room. Subjects were not allowed to 
smoke tobacco for at least fifteen minutes prior to testing to eliminate 
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any effects that the smoke might have had on the TCDC(FO) potential. A 
direct current microvoltometer (Digitest, Model 19) was used for all 
recording and was located in a separate room with the subject monitored 
by means of a two-way mirror. The j[ was grounded to the microvoltometer 
by a metal stretch band on the left wrist. A set of Beckman biopotential 
skin electrodes was used with Beckman electrode paste for all recordings. 
The baseline TCDC potential was measured by applying the electrodes in 
the standard manner, on the midline surface of the head over the frontal 
emissary vein distribution avoiding the frontal sinus area, and over the 
occipital emissary vein distribution just above the superior external 
occipital protuberance. (See Figure 1 for placement of electrodes.) 
INSERT FIGURE 1 ABOUT HERE 
An elastic bandage was wrapped around the head to secure the electrodes 
and to insure constant contact of the occipital electrode. Electrode 
impedance was measured to detect junction artifacts, and electrode 
polorization was checked by touching (shorting) the electrodes together 
and no significant artifacts were encountered. The electrode output was 
fed directly into the dc channel of the microvoltometer, set at 0-100 
millivolts (mv). 
Procedure: E_ met the ^  when he arrived at the laboratory and asked that 
the S^  refrain from smoking for the remainder of the session, and for 
fifteen minutes prior to all subsequent sessions. During the first test 
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session, the E_ administered a drug inventory (see Appendix B) . The jSs 
in all of the present studies were screened on the basis of this ques-
tionnaire. All J3s who used either vitamins or antihistamines were 
excluded because of the drugs' effects on the TCDC(FO), and all Ss who 
reported never using any coffee, tea, aspirin, and tobacco were also 
excluded on the basis of "abnormality". The E_ then seated the S in a 
comfortable lounge chair and connected the ground lead to the subject's 
wrist. The TCDC potential of each S^  was measured and recorded for a 
ten-minute period. Only the maximum frontal negativity reached by the 
^ in the interval was reported. After the Ss were tested, E_ asked them 
to return in a week for a second testing. After the second testing, 
the drug inventory was again administered. Again E_ requested the S^s to 
make a subsequent appointment if they had ingested an LSD-type drug; 
otherwise, an appointment would be made for them in a month to check 
the stability of the measure. 
Four S!s claimed to have ingested a street dose of an LSD-type 
drug; all returned for testing. They were matched according to sex and 
day of testing with jSs who had reported no ingestion of LSD. Thus, of 
the ten Ss, two were not matched nor retested. All drug Ss and their 
matched controls were tested within five to seven days of the reported 
drug experience. 
Results 
Because the TCDC technique is relatively new, and because the 
validity of the parameters is somewhat uncertain, it is difficult to 
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a s c e r t a i n whether or not a change i n the TCDC(FO) from +10 to +15 i s 
e q u i v a l e n t to a change from -5 to 0 . The change in e l e c t r i c a l p o t e n t i a l 
i s obviously the same, bu t the changes i n neurochemistry t h a t produce 
the energy changes may or may not be e q u i v a l e n t . More i m p o r t a n t , i t i s 
imposs ib le to t e l l i f -29 i s e s s e n t i a l l y d i f f e r e n t from -30 mv. 
The peak TCDC(FO) in mv for the drug and non-drug 3^s be fore and 
a f t e r a s i n g l e LSD-type exper ience i s p re sen ted i n Table 2 and Figure 2 . 
INSERT TABLE 2 AND FIGURE 2 
ABOUT HERE 
The mean s h i f t fo r peak TCDC(FO) of the LSD group was - 3 6 . 5 mv (range 
= -28 to -47) from p r e - t e s t t o f i r s t p o s t - t e s t . This was c a l c u l a t e d by 
summing t h e s h i f t s fo r each s u b j e c t and then averag ing . S i m i l a r l y , the 
mean s h i f t of peak TCDC(FO) for the non-drug group was +3.5 mv (range = 
-2 to +7) from p r e - t e s t to f i r s t p o s t - t e s t . The mean s h i f t for each S^  
was a l s o compared to t h a t of h i s matched c o n t r o l . On the b a s i s of 
v i s u a l i n s p e c t i o n of the d a t a , i t was found t h a t t h e r e was no over lap 
i n the peak n e g a t i v i t y of the c o n t r o l group over t ime; however, the peak 
n e g a t i v e TCDC of t h e exper imenta l group d i f f e r ed s i g n i f i c a n t l y wi th no 
over lap from both the c o n t r o l group and t h e i r p re -drug b a s e l i n e s . The 
time of day v a r i a b l e was randomly d i s t r i b u t e d throughout both groups 
and i n t h i s manner i t may have c o n t r i b u t e d - t o group v a r i a n c e , b u t did 
not s i g n i f i c a n t l y b i a s any of the group peak TCDC p o t e n t i a l means. The 
number of days between the exper ience and the p o s t - e x p e r i e n c e t e s t i n g 
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was not a significant variable. One subject, Si, had a TCDC(FO) of -28 
four months after initial ingestion. 
Discussion 
The data indicated that a single ingestion of reported LSD caused 
a long-term change in the electrical activity of the brain, similar to 
that reported in Cowen's studies of hallucinating schizophrenics. The 
TCDC(FO) technique can presumably be used as a diagnostic tool to 
detect the biochemical changes that occur with the use of an LSD-type 
hallucinogen. 
It is interesting to note that only one of the four experimental 
subjects reported experiencing an hallucination (visual), and that the 
£[ had by far the highest peak negativity (-41 mv) . It would have been 
desirable to continue testing all the Ss periodically, until their base-
lines returned to normal but, unfortunately, all subjects were lost to 
further study because they had either ended contact or resumed using 
psychedelic drugs. 
STUDY II 
Purpose 
Study I indicated that the LSD-induced changes in TCDC recordings 
may be permanent or at least long lasting. Cowen's report of frontal 
negativity exceeding -30 mv in patients who had not reported an hallu-
cination in years also suggested brain changes of substantial longevity. 
Study II was designed to examine this seemingly long-lasting change. 
Method 
Subjects: The subjects were six male previously LSD-active members of 
the university community. These subjects, between the ages of 18 and 
30, had participated in a separate pilot study (Golemba, 19 70; see 
Appendix C) while they were frequent users of LSD-type drugs. The E_ 
requested further tests and the Ss, who had stopped using "hard drugs" 
for some four to five months previous, volunteered. 
Apparatus: The initial testing was performed using the same apparatus 
used in Study I. For final recording, the leads from the Beckman bio-
potential electrodes were attached to a standard physiograph ( E & M, 
Model II). 
Procedure: The general procedure was the same as that used in Study I. 
Initial and final testing were administered at the same time of day 
approximately one week apart. The E_ then administered a drug usage 
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inventory, which is presented in Appendix B. Those S^s who were using 
vitamins or antihistamines were excluded from this study. 
Results 
Table 3 summarizes the peak TCDC(FO) in mv for LSD-active indivi-
duals during a period of high usage and after a period of abstinence. 
INSERT TABLE 3 ABOUT HERE 
Visual inspection of Figure 3 shows that there is a significant differ-
ence (no overlap) in the peak negativity TCDC(FO) of the Before and 
After groups. 
INSERT FIGURE 3 ABOUT HERE 
The mean peak TCDC(FO) shift from usage to abstinence was +38.3 mv 
(range = +14 to +56). Every S^  shifted in a positive direction and was 
well within the normal range after abstinence. It is interesting to 
note that three of the subjects (S2, S3, and S5) fell just within the 
normal range even during their period of high usage. 
The time of day of each recording was held constant and thus did 
not significantly bias the means of the groups. Unfortunately, there is 
not enough evidence to say whether number of "trips" was a significant 
variable. The three subjects who fell just within' the normal range had 
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fewer trips than those who fell within the abnormal range. 
Discussion 
The changes in peak TCDC(FO) induced by an LSD experience were of 
considerable but limited length. It was interesting to note that the 
two subjects with the highest negativity were the only ones who reported 
hallucinations. This may have been due to the dosage taken: the 
greater the amount of LSD, the greater the frontal negativity. It is 
also interesting to note that all Ss in this study returned to normal 
range within an average of 13.2 weeks (range = 9 to 20), as opposed to 
an abnormal TCDC(FO) for j[l of Study I, twenty weeks after a single 
dose of LSD. Either the duration of biochemical changes is highly 
individualistic or the subject experienced further unreported LSD usage. 
STUDY III 
Purpose 
Study III was designed to examine more fully some electrophysio-
logical concomitants of two types of hallucinations: chemogenic, and 
hypnogenic. Feinberg (1962) stated, "The more complex and organized 
hallucinations (Stage IV of Kluver) induced in some persons by these 
drugs [hallucinogens] do resemble schizophrenic hallucinations". And 
Halpern (1961) has argued "that there is no essential qualitative differ-
ence between psychogenic [hypnogenic] and toxicogenic [chemogenic] 
hallucinations". 
Method 
Subjects: The £[s comprised two groups: chemogenic and hypnogenic. The 
chemogenic subjects were eight volunteers recruited from the university 
community by the same circular that was used in Study I. The chemogenic 
subjects were drug-active during testing; three were purportedly under 
the influence of LSD, and the other five claimed to be under the influ-
ence of marijuana. (The marijuana users were LSD-naive.) Since all 
drugs were street drugs and the Ss had consumed them before arriving at 
the test laboratory, the dosage of active ingredients was impossible to 
calculate. 
For the hypnotic groups, a total of six highly susceptible Ss (one 
of the six chosen was lost to analysis due to machine failure) and six 
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unsusceptible JSs were selected for the experiment from a total of 
twenty-five volunteers recruited from Introductory Psychology classes at 
the University of Waterloo. The E_ initially selected the j>s on the 
basis of their high scores (7 to 10) on the Harvard Group Scale of 
Hypnotic Susceptibility (HGSS, Shor and Orne, 1962). The unsusceptible 
Ss were selected on the basis of a score of 0 to 5 on the HGSS and were 
assigned to a simulating condition. As suggested by Hilgard and Tart 
(1966) , simulators were used to minimize the possibility of their be-
coming inadvertently hypnotized during the course of the experiment. 
Apparatus: Recording of the chemogenic JSs was performed on a direct 
Current microvoltometer (Digitest, Model 19), and all recording of the 
hypnogenic Ss was performed on a two-channel dynograph (Beckman, type R 
polygraph). In both cases, Beckman biopotential skin electrodes were 
used with Beckman electrode paste. 
The stimulus for positive hallucinations was a five-by-seven-inch 
white card with one completed triangle and one incomplete triangle drawn 
on it with a black felt-tip pen (see Figure 4). 
INSERT FIGURE 4 ABOUT HERE 
The S^  was asked to hallucinate the closure of the incomplete triangle. 
Procedure: The general procedure was the same as that of Studies I and 
II. However, transtemporal recordings were made simultaneously with 
frontal-occipital recordings (see Figure 1 for electrode placement). 
21 
All recordings were made at 5 mv/cm sensitivity and the peak negativity 
was recorded. 
Chemogenic subjects were retested approximately one week after 
initial testing. During retest, the chemogenic subjects were drug-
active, that is, the marijuana subjects were under the influence of 
marijuana and the LSD subjects were under the influence of LSD. 
The research team was constituted as directed by The Hypnosis 
Act, and the hypnosis was carried out by a supervised clinical doctoral 
candidate at the University of Waterloo. 
The E_ met the subjects in the hypnotic group at the laboratory 
and ushered them into the testing room. The E_ requested the ;S_ to sit 
in a comfortable lounge chair and while the electrodes were applied, 
the nature of the experiment was explained. The E_ asked the j[s who 
scored low on the HGSS, to co-operate with whatever the hypnotist (E2) 
instructed them to do even though they would not be hypnotized, i.e., 
because of their low score on the HGSS, they could not be hypnotized. 
The E_ told the Ss who scored high on the HGSS that they would be hypno-
tized and asked to perform certain tasks. To evaluate the effect of 
suggestions on the TCDC, the E requested both groups to be completely 
honest in the post-experimental interview. 
After the E_ delivered the instructions, he went to an adjoining 
room to obtain TCDC basal recordings. Recordings were continuous up 
until the beginning of the post-experimental interview. Then the E2 
met the subject and delivered hypnotic suggestions adapted closely from 
those used on the Stanford Hypnotic Susceptibility Scale (SHSS, 
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Weitzenhoffer and Hilgard, 1962). When the S_ appeared to be deeply 
hypnotized, the E2 gave instructions and suggestions for the unstruc-
tured hallucination. The E2 told the S.: 
In a moment I want you to imagine yourself walking 
down a circular staircase. You cannot see the 
bottom, but when you get to the bottom you will 
see a scene, a very nice scene. You or I have no 
idea what that scene will be, but it will be a 
pleasant one . . . you are reaching the bottom; 
you can see it now. 
Here the E2 is suggesting a complex visual hallucination not unlike 
Stage II of Kluver. The S^was, after sixty seconds, asked to return up 
the staircase, leaving the scene behind. After having the S^  relax and 
deepening the trance, the E2 delivered suggestions for the second phe-
nomenon - dreaming: 
In a moment you are going to have a dream; it will 
be a real dream just like you experience at night. 
Here the E2 is suggesting a dream state in order to compare TCDC 
effects, if any, of dream images vs. hallucinatory images. 
After again relaxing the S^  and deepening the trance, the E2 gave 
instructions for the positive hallucination. The E2 explained to the S^  
that he was going to show him a five-by-seven-inch display card on which 
there were two triangles printed. Before actually opening his eyes, the 
S± was given further instructions to deepen hypnosis and then to open his 
eyes and describe what.he saw on the card. The S^  was then asked to close 
his eyes and deepen the trance. 
Here the E2 is suggesting a positive hallucination and implicitly 
eliciting a report of "I see two triangles". 
One ^  (S_8) was subsequently given further suggestions to produce 
anesthesia, and then the E2 awoke the S^  and told him that the E_ would 
remove the electrodes momentarily. 
Results 
Hypnotic and Simulator Groups: All the Ss who scored high on the HGSS 
reported being hypnotized, while only one (S_4) of those scoring low re-
ported being hypnotized. Table 4 summarizes the subjective reports of 
the j3s concerning their hypnotic experiences. 
INSERT TABLE 4 ABOUT HERE 
All subjects in the hypnotic group and one S_ in the simulator group re-
ported that they "felt" hypnotized. All but one of the hypnotic group 
experienced the dream and the fantasy, and only one subject experienced 
the positive hallucination. Only one subject was given the hypnoanal-
gesic command and he reported it as being effective. Most of the sub-
jects who reported experiencing the dream and the fantasy exhibited 
rapid eye movements (REM's) with eyelids closed as would be expected 
during night sleep. 
Table 5 summarizes the peak TCDC(FO) changes of both the hypnotic 
Ss and the simulators. 
INSERT TABLE 5 ABOUT HERE 
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There was no consistent difference in magnitude nor in direction of the 
TCDC(FO) change associated with hypnosis. Three of the hypnotic Ss 
shifted frontally more positive while two became more negative. In the 
simulating group, two Ss became more frontally positive while four be-
came frontally more negative (including the one simulator who reported 
being hypnotized). The expected negative shifts accompanying hypnogenic 
hallucinations did not occur. There were no differences in magnitude or 
direction between hypnotized j>s who experienced the hallucination, hyp-
notized ^ s who did not experience the hallucination, or simulating Ss. 
Table 6 summarizes the TCDC changes associated with each sugges-
tion. 
INSERT TABLE 6 ABOUT HERE 
The one subject (S_10) who received hypnoanalgesic suggestions reported 
feeling numbed but the anticipated positive shift was absent. This sub-
ject was an excellent hypnotic subject who experienced kinetic halluci-
nations, which are very rare. There were no consistent changes asso-
ciated with any of the hypnotic phenomena exhibited by either the 
hypnotized or the simulating subjects. The trans temporal (TT) record-
ings produced no consistent data associated with any of the hypnotic 
phenomena. The expected left negative shifts associated with vivid 
recall were not evident during the imagery-producing hallucinations. 
Chemogenic Groups. Table 7 summarizes the peak basal TCDC(FO) shifts 
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for both pre-test and test sessions of marijuana users. 
INSERT TABLE 7 ABOUT HERE 
The Ss arrived approximately ten minutes after smoking between one half 
and three of their own marijuana cigarettes. Even a rough estimate of 
the drug potency would be impossible to arrive at. All Ss reported 
their marijuana to be of good quality, and all claimed to be "stoned". 
There was no significant difference between pre-test and drug-active 
test in the peak TCDC(FO) of the Ss. The mean peak TCDC(FO) at pre-test 
was -5.6 mv (range = -15 to +5), while under the influence of marijuana 
the mean was -1.4 mv (range = -10 to +10). Even with the high dosage 
(high in terms of normal use) of three cigarettes, there is no signifi-
cant negative shift that would indicate an LSD-type change. Table 8 
summarizes the peak basal TCDC(FO) shifts for both pre-test and test 
sessions of LSD users. 
INSERT TABLE 8 ABOUT HERE 
The jSs arrived approximately fifteen minutes after the ingestion of one 
tablet of LSD obtained from presumably different sellers on the street. 
Subjective reports of the drug rated it at good quality with little or 
no amphetamine impurities in it. Dosage was probably less than 300 ug 
(Cheek, Newel, and Joff, 1967). During the approximately five hours of 
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t e s t i n g , a l l Ss shif ted in a negative d i rec t ion but with a small 
(A = - 9 . 3 mv) magnitude. The mean peak TCDC(FO) of the LSD users at 
p r e - t e s t was -37 mv (range = -29 to -52) , and at t e s t time the mean was 
-46.3 mv (range = -34 to -55) . The mean sh i f t from p re - t e s t to t e s t 
was -9 .3 mv (range = -3 to -20) . 
Discussion 
Hypnotic Groups. The results of the hypnotic studies suggested that the 
TCDC technique cannot detect any hypnotic effect. Negative results were 
found for the expected TCDC(FO) shift associated with hypnosis. The 
expected negative shift associated with chemogenic and schizophrenic 
hallucinations was not found nor was the expected positive shift asso-
ciated with hypnoanalgesia. Since the hallucinations were experienced, 
it must be concluded that hypnotic hallucinations differ, at least in 
their physiological mechanisms, from schizophrenic and chemogenic 
hallucinations. 
It is interesting to note that S9, a simulator, although beginning 
the hypnotic session with a basal TCDC(FO) of -20 mv, shifted a full 
20 mv in a negative direction, which is an abnormal TCDC(FO) in the 
range of LSD users or hallucinating schizophrenics. Unfortunately, 
there is no apparent explanation for this finding. Perhaps the S^  had 
used an unreported LSD-type drug in the past and was experiencing a 
"flashback" effect. 
Chemogenic Groups. As expected, there were no significant TCDC shifts 
in the marijuana users. This suggests that the mode of action of 
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marijuana i s different from that of LSD. The fa i lure to observe any 
large sh i f t s due to the LSD in toxica t ion i s probably a d i rec t resu l t 
of tolerance to LSD. For th is study to be c learer , LSD-naive subjects 
should have been used. (See Study IV.) 
STUDY IV 
Purpose 
Study IV was designed to examine the TCDC(FO) changes effected by 
various psychedelic drugs in better controlled circumstances than in the 
previous studies. Animals were selected as subjects not only to elimi-
nate legal problems in administering LSD to humans, but also to elimi-
nate scientific problems. Cowen (1970b) has examined the effects of 
LSD on the TCDC in rats and rabbits showing a positive correlation be-
tween peak negativity and reported strength of the hallucinogen 
involved. 
Method 
Subjects: The subjects were four juvenile rhesus monkeys from the 
primate colony at the University of Waterloo. Their weights ranged 
from 3.6 to 5.9 kg. 
Apparatus: An eight-channel dynograph (Beckman, type R polygraph) with 
low level dc input couplers was used for all recording. As before, 
Beckman biopotential skin electrodes were used with Beckman electrode 
paste. All testing of the animals was performed in an enclosure that 
was copper-screened on all sides to eliminate artifacts due to stray 
electromagnetic radiation. Both S^  and E were grounded to the copper 
screen by means of metal stretch bands about the wrist. The electrodes 
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were attached to the monkey and their output was split and fed to two 
sets of two non-interacting channels on the dynograph set at 5 mv/cm 
for baseline voltages and 0.5 mv/cm for transient shifts. 
The three chemicals used in this study were: 1) tetrahydrocanna-
binol (DjTHC, National Institute of Mental Health Lot #61591) suspended 
in fatty-acid free bovine albumin; 2) d-lysergic acid diethylamide-25 
(LSD-25, Sandoz batch #69003); and 3) 2-brom-lysergic acid diethylamide 
(B0L-148, Sandoz batch #433202) , a reportedly non-hallucinogenic ana-
logue of LSD-25. 
Procedure: The E, anesthetized the animals with 60 mg/kg of Nembutal, 
then shaved and washed their heads with alcohol before transporting them 
to the copper-screened room. The JE attached the electrodes, grounded 
both himself and the S^  to the screen, and took basal TCDC(FO) recordings. 
The animals were tested individually. Of the four animals, only one 
received LSD; the other three received control drugs. 
Separate initial injections of NaCl and fatty-acid free bovine 
albumin were given intraperitoneally to S4 to control for the TCDC(FO) 
effects of both the injection itself and for the drug transport medium. 
The E then injected IS1 with 3.5 cc of B0L-148 (5 mg/kg), S2 with .80 cc 
of DjTHC (5 mg/kg), and £3 with .90 cc of LSD-25 (25 Ug/kg). Continuous 
recordings were, taken of the animals TCDC(FO) for a five-hour period. 
Two days later, S3 received a second injection of LSD-25, and J32 
received a second injection of D.THC under the same experimental condi-
tions. The injection of LSD-25 was .84 cc and the D,THC injection was 
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a very large dose of 5.8 cc (36.25 mg/kg) to determine if indeed there 
is a THC dosage effect. The second LSD dose was injected to test for 
a tolerance effect. 
Results 
No characteristic TCDC(FO) effects from either control drug 
injection were detected. The D,THC produced no discernible change in 
the TCDC(FO), even in a large dose. BOL-148 produced a negative FO 
shift of 11 mv, while the initial LSD-25 injection produced a negative 
shift of 180 mv, a significant shift. The second LSD-25 injection pro-
duced a negative shift of 4.8 mv. The TCDC(FO) effects of various com-
pounds in Nembutal-anesthetized monkeys are presented in Table 9. 
INSERT TABLE 9 ABOUT HERE 
Discussion 
There were two provocative and expected findings. The LSD-25 
produced a negative shift in the TCDC of the anesthetized animal. The 
DiTHC data, as expected, showed no change in the TCDC recordings. The 
latter results indicated, as did the tolerance studies, that the mecha-
nism of action of the two psychotropic drugs may be different. The 
small negative shift caused by the injection of the BOL-148 may be due 
to the fact that both LSD-25 and BOL-148 are serotonin antagonists (nega-
tive frontal shift is associated with uptake of serotonin in the brain.) 
LSD-25 is a much more potent antagonist than BOL-148 and this may be 
the mechanism of hallucination (Ray, 1972). 
The lack of a large shift with the second injection of LSD-25 may 
have been due to an overload effect much as that in Study III with the 
LSD-active humans. Two days after the initial LSD-25 injection and 
anesthetized with Nembutal, which drives the TCDC(FO) in a positive 
direction (near zero), the basal TCDC of the ^  was still negative. 
This indicated that the bio-electrical changes induced by LSD-25 had 
not yet subsided. 
This study was somewhat confounded by the use of anesthetized as 
opposed to fully-awake Ss. Unfortunately, surface electrodes cannot be 
kept intact on a fully-awake rhesus monkey for any prolonged period of 
time. Because of the small number of subjects and a single LSD injec-
tion to a naive animal, this study must be considered suggestive rather 
than substantive. For a clearer picture of the LSD effects, a third 
injection of LSD-25 should have been given to an S5 to see if the 
dramatic negative shift was reproducable. At this particular time, 
neither the S nor more LSD was available. 
SUMMARY OF FINDINGS 
Study I showed a significant long-term change in the TCDC(FO) 
activity after a single street dose of reported LSD. The long term 
change was not permanent, as noted by Study II. Study III showed a lack 
of influence on the TCDC(FO) by marijuana, a seeming overload effect of 
LSD, and it also gave no support to the hypothesis that hypnotic and 
chemogenic hallucinations have a common mechanism of action. Study IV, 
using monkeys, supported the results of the human studies. LSD had a 
strong effect upon the TCDC(FO) causing a large negative shift. There 
seemed to be a tolerance effect caused by the LSD and, finally, LSD and 
THC did not cause similar TCDC changes, which indicated that they have 
different modes of action. 
Discussion 
The present studies replicated to some extent the pioneering work 
of M. A. Cowen. These studies indicated that Cowen's LSD studies in 
rats and rabbits are repeatable in monkeys and humans and that the 
changes are stable. However, the present studies did not support 
Cowen's premise that the TCDC(FO) is related to hallucinations rather 
than to biochemical changes in the brain. 
LSD, unlike marijuana compounds, produced a relatively persistent 
but not permanent change in the users' neurochemistry as reflected by 
TCDC(FO) recordings. Since there is no evidence to suggest that LSD is 
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retained in the organism more than twenty-four hours (Barber, 1970), 
one possible explanation for this long-lasting change is that LSD 
initiates a chain of biochemical reactions that continue long after the 
LSD has been metabolized. This long-term change may be associated with 
changes in brain serotonin levels. 
Hypnotic induction did not produce any characteristic TCDC(FO) 
shifts. This was in agreement with the Ravitz study but in direct oppo-
o 
sition to that of Friedman, et al. At this time, these three studies 
cannot be reconciled. Hypnotically-induced hallucinations did not 
produce the characteristic negative TCDC(FO) and (TT) shifts, and 
hypnoanalgesia did not produce the expected positive shift reported by 
Friedman, et al. The present results indicated either a differing 
physiological mechanism for the hallucinations or that the TCDC effects 
have really nothing to do with hallucinations but are influenced entirely 
by biochemical changes that may or may not be related to hallucinations. 
Certainly the Auerbach study, which found no evidence of hallucinations 
induced by LSD in rhesus monkeys, would support the latter hypothesis. 
These biochemical changes may in fact be a result of the attendant 
anxiety associated with hallucinosis or may be related to the reality 
testing process. Neither reality testing nor anxiety occurred in rela-
tion to the hypnotic hallucinations and perhaps that is the reason the 
expected TCDC(FO) shifts did not occur. There is even some question as 
to whether hypnosis itself exists. Had the hypnoanalgesic suggestions 
produced a positive TCDC(FO) shift, a further study involving the giving 
of an LSD experience by hypnosis to a subject who had experienced LSD 
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and who also had a normal basal TCDC recording (Fogel and Hoffer, 1962), 
would have been carried out. 
This long-term, non-permanent change in neurochemistry may account 
for the occurrence of flashbacks (i.e., spontaneously recurring LSD ex-
periences). Pahnke and Richards (1966), and Smart and Bateman (1967), 
reported that flashbacks typically occur when the individual is under 
stress. This suggestion was put forward because there has never been 
any evidence to suggest that LSD is retained in the organism more than 
twenty-four hours and also no evidence that LSD sets off a chain of bio-
chemical reactions that continue after LSD is metabolized. Results of 
the present studies indicated that either LSD does indeed remain in the 
body (Cowen, 1971, has suggested that the LSD may be bonded to DNA 
molecules), or may set off a very long-lasting biochemical chain 
reaction, i.e., drastic changes in serotonin levels. 
The TCDC technique is a relatively simple electric technique for 
studying biochemical changes in the brain. Unfortunately, we do not yet 
know enough about the neurochemistry of the brain for the technique to 
be highly useful. The technique is analogous to using a stethoscope to 
study the heart. However, the stethoscope is useful only because we 
know a great deal about the physiology and functioning of the heart. 
Until we know more about the brain, the TCDC studies on behavioural 
changes (hypnosis, recall, vivid imaginings, etc.) can only be descrip-
tive. At present they may add to our understanding of the brain but 
cannot be used as a diagnostic tool. 
The TCDC may best be used in neurochemical studies. Sensitive 
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enough to detect the presence of as little as five nanograms of LSD-25 
in the brain of the rat, it can be used to monitor the existence and 
the duration of neurochemical changes. At present, the TCDC can only 
be used like a thermometer in that it can register an abnormality 
without describing it. Although the research of Cowen points to the 
glial cells as the generator of this electrical potential, it must be 
remembered that this is still conjecture and perhaps the changes in 
potential are a result of changes in other systems (i.e. , the sensory 
apparatus). 
LEGAL AND ETHICAL CONSIDERATIONS 
Regardless of the scientific implications of these studies, it is 
also necessary to examine some of the legal and ethical implications. 
That the use of LSD is illegal does not mean that research on LSD users 
is illegal. Since no drugs were directly or indirectly provided for 
the subjects, nor were the subjects explicitly or implicitly encouraged 
.to use drugs (see Appendix A), no law was broken by the E. The present 
research is analogous to the many studies oh prostitution. The re-
searchers in those studies neither encouraged nor condoned illegal 
prostitution, but prostitution obviously had to take place in some sort 
of connection with the research. A difference with LSD research is that 
it could be considered unethical not to study it if one of the outcomes 
was evidence that the thousands of young LSD-users are irreversibly and 
detectably altering their neurochemistry. 
The question of legal privilege could be an important one. 
Although the E_'s files could be subpoenaed by a court, all such files 
are coded to avoid the use of the J3s' names. The only document that 
was retained with names is the signed disclaimer to further protect the 
University (see Appendix A). Since all the subjects were required to 
sign the disclaimer, it would be impossible to distinguish the drug-
users from the non-users on the basis of this record. 
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DIRECTIONS FOR FUTURE RESEARCH 
To examine further the long-term TCDC(FO) changes induced by LSD, 
one particular additional experiment may be proposed. To eliminate the 
problem of using anesthesia (which drives the TCDC(FO) positive), un-
anesthetized rabbits would be used. Unlike monkeys, rabbits are easily 
restrained and it is relatively easy to keep surface electrodes intact 
on the head of a fully-awake rabbit. To insure an immediate effect of 
the LSD on the animal, injections would be given through a surgically-
implanted canula in the internal carotid artery of the animal. Con-
tinuous TCDC(FO) recordings could then be kept from the time of injec-
tion until the animal returned to its basal level. This data could be 
compared with the metabolism rates of LSD-25 to determine whether or 
not the TCDC changes persist after the LSD-25 has been metabolized. 
Using this method and rabbits as subjects, the overload effects of LSD 
could also be examined. 
A number of researchers have been looking at the "endogenous 
hallucinogen" theory as an explanation for the behavioural pattern in 
some types of schizophrenia. The principle treatment method based on 
this theory is megavitamin therapy. The vitamins most often used are 
B3 and C. There is considerable controversy about the effectiveness of 
this particular treatment method. Since the TCDC(FO) potential seems 
to.be monitoring the biochemical changes associated with presumable 
endogenous hallucinogens (i.e., bufotenin, DMPEA, and taraxein), perhaps 
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it could be employed to detect changes, if any, in the neurochemistry of 
the patient before and after megavitamin therapy. If the patient before 
treatment had a TCDC(FO) greater than -30 mv and after treatment had a 
TCDC(FO) in the normal range and also exhibited more "normal" behavioural 
patterns, then this would suggest some validity to the megavitamin treat-
ment and, ultimately, to the endogenous hallucinogen theory. If the 
results of this proposed study were positive, they might indicate mega-
vitamin therapy as a treatment for patients suffering from LSD-induced 
psychosis. 
The TCDC potential, like most other physiological events, is likely 
conditionable. It would be interesting to condition someone to control 
his TCDC and exhibit an abnormal negative TCDC and to record his sub-
jective impressions. Those individuals who have learned to control EEG 
occipital alpha waves report a feeling of euphoria. Perhaps those indi-
viduals who learn to control TCDC abnormal negative potentials would 
report a feeling of being "spaced-out" and experiencing hallucinations. 
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TABLE 1 
A COMPARISON OF DIFFERING ALTERED STATES BY CRITERION 
OF INSIGHT, VOLITION, AND CONSCIOUSNESS 
Dream 
Hypnogogic State 
Hallucination 
Daydream 
Fantasy 
Consciousness 
0 
+ 
+ 
+ 
+ 
Insight 
0 
0 
+ 
+ 
+ 
Volition 
0 
0 
0 
+ 
+ 
0 - Largely Absent + - Largely Present 
FIGURE 1 
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TABLE 2 
PEAK TCDC(FO) IN MV FOR LSD AND NON-DRUG SUBJECTS 
BEFORE AND AFTER A SINGLE LSD-TYPE EXPERIENCE 
s# 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
— 
SEX 
F 
F 
F 
M 
M 
M 
M 
M 
M 
M 
PEAK TCDC(FO) 
T 1 
+12 
-1 
+9 
+1 
+5 
-8 
-3 
+9 
+5 
+2 
T 2 
+6 
+2 
+5 
0 
-3 
+6 
+1 
+10 
-1 
-6 
ALLEGED 
DRUG 
Mescaline 
LSD 
LSD 
LSD 
PROBABLE 
DRUG 
LSD 
LSD 
LSD 
LSD 
# DAYS 
AFTER 
6 
5 
7 
6 
PEAK TCDC(FO) 
T 1 
1 WK. 
-35 
+10 
-28 
-33 
-41 
+5 
+6 
-8 
T 2 
2 WKS. 
-30 
+11 
-30 
-28 
-2 
-2 
T 3 
1 MO. 
-36 
+5 
T 4 
4 MOS. 
-28 
+10 
HALLUCINATE 
No 
No 
No 
Yes 
Mean 
Control (N=4) +3 .3 +0 +4 .3 +2 .3 +5 +10 
Mean LSD (N=4) +2.5 +1 LSD LSD 6 - 3 4 . 3 - 2 9 . 3 -36 -28 
FIGURE 2 42 
PEAK TCDC(FO) FOR EACH DRUG-USER AND HIS MATCHED CONTROL 
BEFORE AND AFTER A SINGLE LSD-TYPE EXPERIENCE 
+ 20 
BEFORE AFTER 
NON-USERS • 1 
LSD-USERS O 
-0- 0 
1 3 5 
TEST DAY 
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TABLE 3 
TCDC(FO) RECORDING IN MV FOR FREQUENT USERS OF LSD 
DURING A PERIOD OF HIGH USAGE AND AFTER ABSTINENCE 
s# 
1 
2 
3 
4 
5 
6 
M 
TCDC(FO) 
T 1 
-49 
-16 
-22 
-38 
-27 
-62 
-35.7 
T 2 
-33 
-28 
-26 
-31 
-24 
-59 
-33.5 
# OF 
TRIPS 
9 
3 
5 
13 
6 
16 
8.7 
HALLUCINATE 
Yes* 
No 
No 
No 
No 
Yes** 
LENGTH OF 
ABSTINENCE 
(BY WEEKS) 
9 
12 
12 
20 
10 
16 
13.2 
TCDC(FO) 
T 3 
+4 
+7 
+12 
+9 
-10 
-3 
3.2 
T 4 
0 
+5 
+18 
+11 
-13 
+10 
5.2 
* Visua l 
** Auditory and Somatic 
FIGURE 3 
PEAK TCDC(FO) IN MV FOR LSD-ACTIVE SS DURING A PERIOD 
OF HIGH USAGE AND AFTER A PERIOD OF ABSTINENCE 
+ 20r- , s 
r«s2 r 
I Wi1 I 
f »*s4 fs6 
oh ^ ; % ' , i 
-40h / ' 
USAGE 
""60 • • ABSTINENCE ff 
1 3 1 3 1 3 1 3 1 3 1 3 
TEST DAY 
FIGURE 4 
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STIMULUS FOR THE INDUCTION 
OF POSITIVE HALLUCINATIONS 
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TABLE 4 
REPORTED HYPNOTIC EXPERIENCES OF HYPNOTIZED 
AND SIMULATING SUBJECTS 
PHENOMENON HYPNOTIZED SIMULATED 
SUBJECT # 3 5 7 10 11 1 2 4 6 8 9 
UNSTRUCTURED HALLUCINATION - - Y Y I - - - - N I 
(STAIRS) 
DREAM INDUCTION Y N Y Y Y N N I N N I 
POSITIVE HALLUCINATION N N Y - - N N N N - -
HYPNOTIZED Y Y Y Y Y N N Y N N N 
ANALGESIA 
Y - Experienced the suggested phenomenon 
N - Did not experience the phenomenon 
I - Experienced imagery but did not experience 
the suggested phenomenon 
TABLE 5' 
PEAK TCDC(FO) CHANGES IN MV OF HYPNOTIC SS AND OF SIMULATING SS ASSOCIATED 
WITH HYPNOSIS PER SE, PRIOR TO HALLUCINATION INDUCTION 
HYPNOTIC 
S# BASAL PEAK BASAL CHANGE HGSS 
3 ' 4 -7 -4 -11 8 
5 2 0 0 - 2 10 
7 16 20 15 4 10 
10 16 26 20 10 8 
11 -28 -20 -20 8 7 
+ 3 
2 
SIMULATOR 
S# BASAL PEAK BASAL CHANGE HGSS 
1 7 30 30 23 5 
2 -1 -3 -2 -2 5 
4* 0 -7 .5 -7 4 
6 -10 -16 -13 -6 4 
8 50 60 51 10 3 
9 -20 -40 -32 -20 3 
2 
4 
* S4 reported being hypnotized. 
*, 
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TABLE 6 
TCDC(FO) SHIFTS IN MV FOR EACH 
HYPNOTIC PHENOMENON 
HYPNOTIC 
HALLUCINATIONS 
S# UNSTRUCTURED DREAM POSITIVE HGSS 
3 - 0 + 1 8 
5 - -1 0 10 
7 0 -2 0 10 
10 +1 +2 +1 8 
11 -1 0 7 
SIMULATOR 
HALLUCINATIONS 
S# UNSTRUCTURED DREAM POSITIVE HGSS 
1 - - 1 0 5 
2 - 0 - 1 . 5 
4 - 0 - 2 4 
6 - + 1 - 2 4 
8 0 0 3 
9 0 -1 . 3 
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TABLE 7 
PRE-DRUG AND DRUG-ACTIVE TCDC(FO) PEAK RECORDINGS 
IN MV FOR MARIJUANA USERS 
s# 
1 
2 
3 
4 
5 
PRE-TEST 
-6 
+5 
-15 
-2 
-10 
DRUG -ACTIVE 
+4 
+10 
-10 
-9 
+1 
SHIFT 
+10 
+5 
-5 
-7 
+11 
ELAPSED 
MENS. 
(APPROX.) 
10 
5 
15 
5 
10 
DOSAGE 
% j o i n t 
1 
1 
3 
h 
X -5.6 -1.4 2.8 1.2 
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TABLE 8 
PRE-DRUG AND DRUG-ACTIVE TCDC(FO) PEAK RECORDINGS 
IN MV FOR STREET-LSD USERS 
S# PRE-TEST DRUG-ACTIVE SHIFT ELAPSED 
MINS. 
(APPROX.) 
1 -30 -50 -20* 10 
2 -52 -55 - 3 25 
3 -29 -34 -5 15 
X -37 - 4 6 . 3 - 9 . 3 16.6 
TABLE 9 
A COMPARISON OF TCDC(FO) SHIFTS OF VARIOUS COMPOUNDS INJECTED 
INTRAPERITONEALLY IN NEMBUTAL-ANESTHETIZED MONKEYS 
SUBJECT 
S# WEIGHT 
IN KG. 
1 5.9 
2 3.8 
3 3.6 
4 4.35 
2* 3.8 
3* 3.6 
INJECTION 
NEMBUTAL 
60 MG/KG 
CC. 
3.5 
2.5 
2.3 
2.8 
2.5 
2.3 
LSD 
25 UG/KG 
C C 
.90 
.84 
NaCl 
9 MG/ 
C C 
1 
THC 
5 MG/KG 
CC. 
.80 
3.8** 
BOL-148 
5 MG/KG 
C C 
3.5 
BOVINE ALB. 
25 GR/5 CC 
C C 
4.00 
TCDC(FO) 
SHIFT 
+ 
0 
0 
0 
+ 
MAGNITUDE 
11 MV 
180 MV 
1 MV 
4.8 MV 
* a second in jec t ion two days a f te r the i n i t i a l in jec t ion 
** a del ibera te overdose (23.75 mg/kg) two days af ter the i n i t i a l i n j e r t ion 
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APPENDIX A 
THE ADVERTISEMENT USED TO RECRUIT VOLUNTEER SUBJECTS 
ELECTRIC COOL-AIDE ACID TEST 
This study is concerned with whether or not the electrical 
activity of the brain changes due to drug use. 
If you volunteer, you will have two recording electrodes placed 
on the scalp. (These are not to be confused with shock electrodes; 
absolutely no discomfort is involved.) You will be asked to sit quietly 
for about ten minutes, during which you will be asked to concentrate on 
a simple mental task, and then to just relax for about five more minutes. 
You will then be given a detailed questionnaire on what drugs you 
have taken. I would like you to come back for repeat measurements once 
a month for three months. If you have used new drugs, this will help 
us determine how they effect brain changes. If you have not used any 
new drugs, you will help us in determining the stability of our measur-
ing techniques. Consequently, the value of your participation does not 
depend on your taking drugs during the experimental period. 
Neither the researcher nor the universities with which he is affi-
liated in any way wish to encourage or condone the use of any non-medical 
drug. No drugs are supplied to subjects in conjunction with this project. 
No payment or reimbursement of any kind can be offered for your partici-
pation. However, interested parties may secure copies of research 
reports resulting from this work. 
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APPENDIX B 
THE DRUG INVENTORY QUESTIONNAIRE USED TO 
DETERMINE THE SUITABILITY OF THE SUBJECT 
The following information will be coded and held in strict confidence. 
Name: 
Age: Sex: Academic Year: 
1. Which of the following drugs have you ever used? How long ago? 
(Please indicate in each case, i.e. , a week, a month, a year.) 
. ) coffee 
) tea 
) tobacco: cigarettes ( ) , pipe ( ), cigars ( ) 
) aspirin 
) cold tablets, e.g., codeine ( ), antihistamines ( ) , vitamins ( ) 
) steroid hormones, e.g., birth control pills 
) stimulants, e.g., amphetamines - oral ( ), intraveneously ( ) 
) tranquillizers ( ) marijuana 
) sedatives ( ) hashish 
) mescaline ( ) psilocybin 
) LSD ( ) MDA 
) STP ( ) belladonna 
) others 
2. Which of the following drugs might you use within the next few weeks? 
( ) coffee ( ) tea 
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3. 
tobacco: cigarettes ( ) , pipe ( ), cigars ( ) 
aspirin 
cold tablets, e.g., codeine ( ), antihistamines ( ), vitamins ( ) 
steroid hormones, e.g., birth control pills 
stimulants, e.g., amphetamines - oral ( ), intraveneously ( ) 
tranquillizers ( ) marijuana 
sedatives ( ) hashish 
mescaline ( ) psilocybin 
LSD ( ) MDA 
STP ( ) belladonna 
others 
Which of the following drugs do you ordinarily use, and how often? 
coffee ( ) tea 
tobacco: cigarettes ( ), pipe ( ), cigars ( ) 
aspirin 
cold tablets, e.g., codeine ( ), antihistamines ( ), vitamins ( ) 
steroid hormones, e.g., birth control pills 
stimulants, e.g., amphetamines - oral ( ), intraveneously ( ) 
tranquillizers 
sedatives 
mescaline 
LSD 
STP 
others 
marxjuana 
hashish 
psilocybin 
MDA 
belladonna 
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APPENDIX C 
LSD EFFECTS ON THE TCDC(FO) POTENTIAL: A PILOT STUDY 
This pilot study was designed to determine whether or not "street-
LSD" caused a negative shift in the transcephalic direct current poten-
tial (TCDC) in the user. No attempt was made to control for time of 
testing, sex of the subject, temperature and humidity of the setting, 
location of testing, or previous drug usage. Many of the subjects were 
tested at "rock festivals" and in student lounges. However, some of the 
j3s, including those reported in Study II, were tested under standard 
conditions and using standard procedures. Some of the subjects (both 
users and non-users) in this pilot were personal friends of the experi-
menter. 
The subjects were forty-three LSD-users and thirty-seven non-
users. Presumably some of the Ss were drug-active at the time of test-
ing. Many of the ^ s in both groups had used marijuana. 
The S_ was asked if he would like to participate in the "Electric 
Cool-Aide Acid Test" and was told that it was a test to determine 
whether LSD caused changes in the brain. The S_ was assured that no 
discomfort would take place. Electrodes (Beckman, biopotential) were 
placed on the scalp over the frontal and occipital (FO) areas (see 
Figure 1). The wires of the electrodes were fed into a voltometer 
(Digitest, Model 19) and the S_was asked to relax and close his eyes. 
The TCDC(FO) was monitored for a five-minute period and the frontal 
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s h i f t was noted and recorded . 
There was no over lap between the TCDC(FO) of LSD-users and non-
u s e r s . No non-user had a TCDC(FO) of l e s s than -16 mv (x = +4, range 
= -15 to +80) , and no LSD-user had a TCDC(FO) of g r e a t e r than -20 mv 
(x = - 4 1 , range = - 7 1 t o - 2 0 ) . 
The da ta i n d i c a t e d t h a t LSD caused a f r o n t a l n e g a t i v e s h i f t in 
the TCDC(FO) not u n l i k e t h a t seen in h a l l u c i n a t i n g s c h i z o p h r e n i c s . 
Because of the l a x c o n t r o l s i n t h i s p i l o t s t udy , i t was imposs ib le to 
make any s t rong conc lus ions . 
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